Method for establishing eosinophilic granulocyte proportion model by utilizing nasal polyp pathological picture

A technology for eosinophils and nasal polyps, which is applied in the field of establishing eosinophil proportion models using pathological pictures of nasal polyps, can solve the problems of measurement deviation, high time cost, lack of accuracy and timeliness of auxiliary diagnosis system, etc.

Active Publication Date: 2020-01-31
THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIV +1
View PDF4 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, due to different experiences of different doctors, or the same doctor at different times, the sampling estimates obtained by randomly selecting the field of view are also different, that is, artificial random sampling counts may also have measurement bias
[0004] Statistics of the proportion of eosinophils to inflammatory cells on the entire slide specimen can make a more accurate diagnosis and avoid sampling errors. However, pathologists need to spend 2 to 4 hours to fully count a slide specimen, and the time cost is extremely high
[0005] The clinical diagnosis of chronic sinusitis depends entirely on the experience of pathologists at this stage, and lacks an objective, highly accurate and timely auxiliary diagnosis system

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for establishing eosinophilic granulocyte proportion model by utilizing nasal polyp pathological picture
  • Method for establishing eosinophilic granulocyte proportion model by utilizing nasal polyp pathological picture
  • Method for establishing eosinophilic granulocyte proportion model by utilizing nasal polyp pathological picture

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without creative work all belong to the protection scope of the present invention.

[0025] The present invention utilizes nasal polyp pathological picture to establish the method for eosinophil proportion model, comprises the following steps:

[0026] (1) Data preparation: Nasal polyps are made into slides, and then scanned by a digital pathology instrument to obtain a WSI image, and the WSI is cut to obtain a small pathological image. WSI is the abbreviation of whole slide image, that is, a digital pathological image;

[0027] In the d...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for establishing an eosinophilic granulocyte proportion model by utilizing a nasal polyp pathological picture, and the method comprises the following steps: preparingdata, manufacturing nasal polyp into a slide, scanning by using a digital pathological instrument to obtain a WSI picture, and cutting the WSI picture to obtain small pathological pictures; dividing all the small pathological pictures into training set data and test set data according to a set proportion; establishing the eosinophilic granulocyte proportion model; performing training on an ImageNet data set by adopting an Inception V3 model to obtain model parameters, removing the last full connection layer FC of the model, adding a full connection layer FC, wherein only one neuron is arranged in the full connection layer FC, and no activation function is adopted; setting a loss function to employ a mean square error MSE, and setting a learning rate lr. The method is applied to a chronicnasosinusitis nasal polyp pathological auxiliary diagnosis system, and the eosinophilic granulocyte proportion on a pathological picture is rapidly and accurately obtained through learning and training.

Description

technical field [0001] The invention relates to the technical field of medical treatment means, in particular to a method for establishing an eosinophil proportion model using nasal polyp pathological pictures. Background technique [0002] Chronic rhinosinusitis (CRS) can be clinically divided into two types: without nasal polyps (CRSsNP) and with nasal polyps (CRSwNP). Chronic sinusitis with nasal polyps (CRSwNP) is subdivided into two subtypes: eosinophilic nasal polyps (eCRSwNP) and non-eosinophilic nasal polyps (neCRSwNP). Eosinophilic nasal polyps (eCRSwNP) were sensitive to steroid therapy, whereas non-eosinophilic nasal polyps (neCRSwNP) were sensitive to macrolide antibiotics. Clinically, for how to define eosinophilic nasal polyps (eCRSwNP) and non-eosinophilic nasal polyps (neCRSwNP), pathologists usually randomly take 10 high-power fields of eosinophilic nasal polyp slide specimens from patients The average percentage of granulocytes, and using 10% as the cut-o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G16H30/40G16H50/20G16H50/50G06N3/08G06N3/04
CPCG16H50/50G16H50/20G16H30/40G06N3/08G06N3/045
Inventor 杨钦泰韩蓝青任勇吴庆武陈健宁邓慧仪孙悦奇袁联雄王玮豪郑瑞洪海裕孔维封黄雪琨袁田邱惠军李权黄桂芳叶俊杰王伦基
Owner THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products